EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review

Claudia Maria Jurca, Kinga Kozma iD, Codruta Diana Petchesi iD, Dana Carmen Zaha iD, Ioan Magyar, Mihai Munteanu iD, Lucian Faur, Aurora Jurca, Dan Bembea, Emilia Severin, Alexandru Daniel Jurca

Genes · 2023

DOI: 10.3390/genes14020433 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Claudia Maria Jurca und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410081 Oradea, Romania. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Diabetes Mellitus, Type 2, Epilepsy, Metformin. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oradea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors present the case of a 33-year-old female patient registered with the Bihor County Regional Center of Medical Genetics (RCMG) since 2021 with a TSC diagnosis. She was diagnosed with epilepsy at eight months old. At 18 years old she was diagnosed with tuberous sclerosis and was referred to the neurology department. Since 2013 she has been registered with the department for diabetes and nutritional diseases with a type 2 diabetes mellitus (T2DM) diagnosis. The clinical examination revealed: growth delay, obesity, facial angiofibromas, sebaceous adenomas, depigmented macules, papillomatous tumorlets in the thorax (bilateral) and neck, periungual fibroma in both lower limbs, frequent convulsive seizures; on a biological level, high glycemia and glycated hemoglobin levels. Brain MRI displayed a distinctive TS aspect with five bilateral hamartomatous subependymal nodules associating cortical/subcortical tubers with the frontal, temporal and occipital distribution. Molecular diagnosis showed a pathogenic variant in the TSC1 gene, exon 13, c.1270A>T (p. Arg424*). Current treatment targets diabetes (Metformin, Gliclazide and the GLP-1 analog semaglutide) and epilepsy (Carbamazepine and Clonazepam). This case report presents a rare association between type 2 diabetes mellitus and Tuberous Sclerosis Complex. We suggest that the diabetes medication Metformin may have positive effects on both the progression of the tumor associated with TSC and the seizures specific to TSC and we assume that the association of TSC and T2DM in the presented cases is accidental, as there are no similar cases reported in the literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberous SclerosisDiabetes Mellitus, Type 2EpilepsyMetforminFemaleHumansAdultInfantAdolescentTumor Suppressor ProteinsTuberous Sclerosis Complex 2 ProteinTuberous Sclerosis Complex 1 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSeizuresTOR Serine-Threonine KinasesSignal Transduction

Stichwörter der Autor:innen

MetforminTSC1TSC2epilepsyhamartomastuberous sclerosistype 2 diabetes mellitus

Substanzen

Tumor Suppressor ProteinsTuberous Sclerosis Complex 2 ProteinTuberous Sclerosis Complex 1 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesMetforminMTOR protein, human

Autor:innen und Institutionen

  • Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410081 Oradea, Romania.
  • Regional Center of Medical Genetics Bihor, County Emergency Clinical Hospital Oradea (Part of ERN-ITHACA), 410469 Oradea, Romania.
  • Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410081 Oradea, Romania.
  • Faculty of Medicine and Pharmacy, University of Oradea, 410081 Oradea, Romania.
  • Faculty of Medicine, University of Medicine and Pharmacy "Iuliu Hațieganu", 400012 Cluj Napoca, Romania.
  • Department of Genetics, University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania.

ORCID-Profile: Kinga Kozma, Codruta Diana Petchesi, Dana Carmen Zaha, Mihai Munteanu

Förderung

  • University of Oradea

Zitieren

APA

Jurca, C. M., Kozma, K., Petchesi, C. D., Zaha, D. C., Magyar, I., Munteanu, M., Faur, L., Jurca, A., Bembea, D., Severin, E., & Jurca, A. D. (2023). Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review. Genes. https://doi.org/10.3390/genes14020433

Vancouver

Jurca CM, Kozma K, Petchesi CD, Zaha DC, Magyar I, Munteanu M, et al. Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review. Genes. 2023. doi:10.3390/genes14020433

BibTeX
@article{Jurca2023,
  author = {Jurca, Claudia Maria and Kozma, Kinga and Petchesi, Codruta Diana and Zaha, Dana Carmen and Magyar, Ioan and Munteanu, Mihai and Faur, Lucian and Jurca, Aurora and Bembea, Dan and Severin, Emilia and Jurca, Alexandru Daniel},
  title = {Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways—Case Report and Literature Review},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14020433}
}
Kostenlos starten →